-
Barred from elections, Russia's anti-war party vows to fight on
-
Caught between great powers: the cautionary tale of Manus
-
Jaissle states Newcastle ambition but urges patience
-
Heatwave hits evicted families sleeping rough in Rome
-
NBA star Cooper Flagg trading card a slam dunk for lucky buyer
-
US company stokes Greenland tensions by unloading drilling gear
-
ForumPay Expands Payment Infrastructure with New Card and Bank Transfer Acceptance Solution
-
Cambridge academic in plagiarism row publishes memoir
-
Oil prices higher, stocks flat ahead of inflation report
-
LeBron's Sixers hope to spoil Knicks party on NBA opening night
-
Orban-critic ex-judge becomes Hungary president after predecessor ouster
-
UK 'on course' to record warmest summer for second year in a row
-
US rights groups sue Trump over ICC sanctions
-
Spotify to launch badge identifying AI music
-
Sphere 3D Corp. (Nasdaq: ANY) Attracts 6.5% Stake from Turnaround Bitcoin-Mining Investor
-
New plastic treaty document criticised for weaker ambition
-
Oil prices lower, stocks higher as Hormuz doubts drag on
-
Hungary parliament approves Orban-critic judge as president
-
Colombia scrambles to find survivors as quake kills 181
-
Ebola outbreak in DR Congo kills more than 2,000
-
Colombia scrambles to find survivors as quake kills 169
-
ChargeAfter Powers BYLD Finance Expansion into Consumer Financing for Equipment Retailers
-
MEXC Report: 74.2% of Traditional Finance Users Have Shifted Their Trading Activity to Crypto Exchanges
-
MEXC Upgrades RealStocks With Three New Features to Enhance U.S. Stock Trading Experience
-
MEXC Lists DAPPOS (DOS) With $60,000 Worth of DOS and 10,000 USDT in Airdrop+ Rewards
-
Israel demolishes home of slain Palestinian involved in deadly West Bank clash
-
Jellyfish force shutdown of three reactors at French nuclear plant
-
Liverpool fans seek clarity on Bezos bid to buy stake
-
Hodgkinson, Werro sail through Euro 800m qualifying
-
Solar eclipse sparks scramble for protective glasses across Europe
-
Somali referee denied World Cup 'proud' to oversee UEFA Super Cup
-
Oil prices jump as US-Iran deal hopes falter
-
French newspapers target Google over AI summaries
-
Newly crowned world's best pastry chef stays true to artisan roots
-
Ebola death toll in DR Congo outbreak rises to more than 2,000
-
Johnson signs for Everton in McNeil swap deal
-
PrimeXBT Launches MT5 Cent Account for Beginners and Risk-Conscious Traders
-
Syria sentences Bashar al-Assad to death in absentia over atrocities
-
British sprinter Hunt chasing three more golds after winning 100m
-
Hong Kong's tech index plans expansion with AI and robotics themes
-
Ethiopia's Tigray rebel authorities condemn army drone strikes
-
The Infantino saga -- What they said
-
Too hot to live? French buyers rethink housing choices after heatwaves
-
Economic losses from natural disasters fall to $100 bn in first half of 2026: Swiss Re
-
Ukraine says Russia fired N. Korean missiles in deadly attack
-
Colombia scrambles to find survivors as quake kills 132
-
Oil prices jump further as hopes for Hormuz deal fade
-
Singapore says AI-related demand lifting economy
-
Trump says would be 'terrible mistake' to oust embattled Infantino
-
Demeter Tactical Investments (ME) Limited bolsters governance with two board appointments
Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
C.Hamad--SF-PST